DI FRANCESCO, JACOPO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 6.759
EU - Europa 3.426
AS - Asia 2.713
SA - Sud America 521
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 5
Totale 13.478
Nazione #
US - Stati Uniti d'America 6.612
SG - Singapore 926
CN - Cina 809
DE - Germania 719
IT - Italia 642
RU - Federazione Russa 523
BR - Brasile 441
HK - Hong Kong 439
SE - Svezia 391
IE - Irlanda 283
GB - Regno Unito 217
FI - Finlandia 174
UA - Ucraina 167
VN - Vietnam 165
CA - Canada 111
IN - India 85
FR - Francia 77
TR - Turchia 46
AT - Austria 44
JP - Giappone 38
ID - Indonesia 32
KR - Corea 32
BE - Belgio 31
DK - Danimarca 30
PL - Polonia 29
BD - Bangladesh 27
AR - Argentina 25
ZA - Sudafrica 25
ES - Italia 24
NL - Olanda 23
IQ - Iraq 22
MX - Messico 18
EC - Ecuador 17
CL - Cile 14
UZ - Uzbekistan 13
IR - Iran 12
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
SA - Arabia Saudita 8
EU - Europa 7
PY - Paraguay 7
VE - Venezuela 7
DO - Repubblica Dominicana 6
LT - Lituania 6
MA - Marocco 6
GE - Georgia 5
PT - Portogallo 5
AL - Albania 4
AZ - Azerbaigian 4
PH - Filippine 4
RO - Romania 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BH - Bahrain 2
CO - Colombia 2
EE - Estonia 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
MU - Mauritius 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SC - Seychelles 1
SR - Suriname 1
TH - Thailandia 1
Totale 13.475
Città #
Ann Arbor 1.487
Singapore 684
Ashburn 573
Hong Kong 437
Chandler 410
Fairfield 392
Woodbridge 392
Frankfurt am Main 373
Wilmington 340
Dublin 274
Houston 264
Milan 225
Santa Clara 194
New York 190
Jacksonville 176
Munich 174
Dearborn 160
Beijing 154
Seattle 153
Cambridge 132
Princeton 114
Los Angeles 111
Helsinki 110
Dallas 97
Nanjing 80
Shanghai 66
São Paulo 61
Hefei 54
Moscow 53
Buffalo 47
Lawrence 47
Chicago 39
Altamura 38
Dong Ket 37
Vienna 35
Ho Chi Minh City 32
Lachine 30
Council Bluffs 29
Hanoi 29
Jakarta 29
Seoul 28
Boardman 26
Guangzhou 26
Brussels 24
Brooklyn 23
Andover 22
Denver 22
Jinan 22
Ottawa 22
Tokyo 22
Grafing 21
London 21
Monza 21
Nuremberg 20
San Diego 20
Warsaw 20
Montreal 19
Nanchang 19
Pune 19
Fremont 18
Toronto 18
Rome 17
Changsha 16
Stockholm 16
Zhengzhou 16
Boston 15
Orem 15
Shenyang 15
Tianjin 15
Kocaeli 14
Phoenix 14
Ankara 13
Columbus 13
Johannesburg 13
Rio de Janeiro 13
Santiago 13
Tashkent 13
Turku 13
Atlanta 12
Falls Church 12
Poplar 12
Salt Lake City 12
The Dalles 12
Hebei 11
Manchester 11
Hangzhou 10
Lissone 10
Chennai 9
Curitiba 9
Edmonton 9
Jyväskylä 9
Leawood 9
Monmouth Junction 9
San Francisco 9
Jiaxing 8
Mountain View 8
Baghdad 7
Bari 7
Detroit 7
Florence 7
Totale 9.228
Nome #
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 443
Cardiac and neuronal HCN channelopathies 421
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 391
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 371
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 358
Effect of the ketogenic diet in excitable tissues 351
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 345
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 305
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 303
Generation and validation of algorithms to identify subjects with dementia using administrative data 298
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 297
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 279
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 274
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 270
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 269
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 250
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 249
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 247
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 246
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 245
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 244
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 240
Brain targets: can you believe your own eyes? 230
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 228
Cerebral Amyloid Angiopathy-Related Inflammation 221
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 213
A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation 213
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 207
HCN1 novel mutations in familiar generalized epilepsy 203
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 201
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 201
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 198
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 198
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines 194
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 194
Autoimmune encephalopathy in Graves' disease: Remission after total thyroidectomy 193
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 193
Cerebral amyloid angiopathy-related inflammation: an emerging disease 190
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 187
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 185
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 182
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 181
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 181
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 180
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study 180
Epilptic seizures and psychogenic non-epileptic seizures 179
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 179
Neurological soft signs are increased in migraine without aura: relationship with the affective status 172
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 171
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 170
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 167
Epilepsy in Cerebral Amyloid Angiopathy: an observational retrospective study of a large population 165
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 164
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 162
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 152
Complicanze neurologiche di malattie internistiche 151
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 151
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 149
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 135
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 131
LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS 128
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 125
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 125
Totale 14.025
Categoria #
all - tutte 45.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.138 0 0 0 0 121 140 147 174 147 151 109 149
2021/20221.015 119 111 115 84 84 94 34 46 50 48 78 152
2022/20231.695 162 472 158 188 124 237 34 82 167 11 25 35
2023/20241.056 27 62 49 69 152 257 162 56 78 11 17 116
2024/20252.687 135 283 156 97 216 180 250 153 280 388 211 338
2025/20262.743 722 295 481 837 408 0 0 0 0 0 0 0
Totale 14.025